Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Feasibility Study of Enteral Levetiracetam vs. Phenobarbital for Seizure Control in Pediatric Cerebral Malaria

NCT01982812 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT01982812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01982812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Feasibility Study of Enteral Levetiracetam vs. Phenobarbital for Seizure Control in Pediatric Cerebral Malaria
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
June 30, 2015
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral malaria, epilepsy, seizure